A Pivotal, Double-Blind, Randomized, Placebo-Controlled, Multinational Study of SGX942 (Dusquetide) for the Treatment of Oral Mucositis in Patients Being Treated with Concomitant Chemoradiation for the Treatment of Squamous Cell Carcinoma of the Head and Neck

IRB/UVA Tracking #
21217
Contact
Olusegun Adelaja
Contact Phone
Phase
III
Primary purpose
Supportive Care
Cancer PI
Varinder Kaur
Status
OPEN TO ACCRUAL